Vitro Biopharma, Inc VTRO IPO will take place September, 13 on the NASDAQ exchange under the ticker VTRO.
The company is offering shares at an expected price between $5.00 and $6.00 per share with an insider lock-up period of 180 days ending on March 11, 2024.
See also: Benzinga IPO Calendar
About Vitro Biopharma, Inc
Vitro Biopharma, Inc is an innovative biotechnology company targeting autoimmune diseases and inflammatory disorders, with an ancillary focus in the research services and cosmeceutical fields. With respect to our regenerative medicine business
See also: Benzinga's Most Shorted Stocks
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
